Skip to main content

Cryofibrinogen, Qualitative

CPT 82585

Test Details

Methodology

Visual observation of refrigerated samples

Result Turnaround Time

3 - 5 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

Detect cryofibrinogen complexes in plasma1

Limitations

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Custom Additional Information

Cryofibrinogen is an abnormal complex of proteins that precipitate out of plasma as it is cooled.1 These cold, insoluble protein complexes can be composed of fibrin, fibrinogen, fibrin split products, along with other plasma proteins. Cryofibrinogen forms in refrigerated plasma, but not in refrigerated serum.1 Protein precipitate that forms in both refrigerated serum and refrigerated plasma is referred to as cryoglobulin. Testing for cryofibrinogen requires the collection of serum (see Cryoglobulin, Qualitative With Quantitative Reflex [001594]) in order to exclude the presence of cryoglobulin in the patient sample.1 Cryofibrinogen can occur spontaneously (ie, essential cryofibrinogenemia) or in association with other inflammatory conditions. Secondary cryofibrinogenemia has been reported in patients with malignancy, diabetes mellitus, collagen vascular disease, and active infection.1 Most individuals with cryofibrinogenemia are asymptotic.1 Morbidity associated with cryofibrinogenemia occurs as the result of thrombotic occlusion of the small to medium arteries by insoluble protein complexes. Cryofibrinogenemia can produce symptoms due to cutaneous ischemia including purpura, livedo reticularis, ecchymosis, ulcerations, or ischemic necrosis. These symptoms are typically observed in areas of the body that tend to be at lower temperature including the hands, feet, ears, nose, and buttocks.1 Less specific symptoms, such as malaise and fever, are also relatively common manifestations of the condition. In some rare cases, essential cryofibrinogenemia has been associated with cutaneous ulcers and gangrene.1 Cryofibrinogenemia has infrequently been associated with other conditions including cerebrovascular thrombosis; myocardial infarction; thrombophlebitis; obstruction of the aortic, ileac, or femoral artery; pulmonary emboli; mesenteric artery thrombosis; and retinal artery thrombosis.1 These thrombotic conditions can occasionally produce spontaneous bleeding due to depletion of clotting factors, similar to that seen in disseminated intravascular coagulation (DIC).1

Specimen Requirements

Specimen

Plasma

Volume

3 mL

Minimum Volume

1 mL

Container

Blue-top (sodium citrate) tube, lavender-top (EDTA) tube, or gray-top (sodium fluoride) tube

Collection Instructions

Specimen must be drawn in a prewarmed tube and kept at 37°C. Separate plasma from cells immediately, and transfer the plasma into a clean transport tube. Label transport tube "Prewarmed."

Reference Range

None detected

Storage Instructions

Maintain specimen at room temperature.

Causes for Rejection

Heparinized plasma; whole blood received

Footnotes

1. Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med. 2004 Mar 1; 116(5):332-337. 14984819

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
080317 Cryofibrinogen, Qualitative 11043-7 080317 Cryofibrinogen, Qualitative 11043-7
Order Code080317
Order Code NameCryofibrinogen, Qualitative
Order Loinc11043-7
Result Code080317
Result Code NameCryofibrinogen, Qualitative
UofM
Result LOINC11043-7